CatalystPit

TYRATyra Biosciences, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $21.87 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$1.31B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-17 · Harris Todd (President and CEO) · OTHER
  • 2026-09-17 · Fuhrman Alan (Chief Financial Officer) · OTHER
  • 2026-09-17 · Rueb Yuliya (Vice President, Finance (PAO)) · OTHER
  • 2026-09-11 · Verjee Rehan (Director) · BUY
  • 2026-05-07 · Rueb Yuliya (Vice President, Finance (PAO)) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders179
Shares held87,006,052
Value$2.55B
Percent of shares outstanding145.80%
As of quarter end2026-06-30
RECENT NEWS
  • TYRA: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
  • TYRA: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
  • Cantor Fitzgerald reiterates rating on Tyra Biosciences
  • Tyra prices $400M offering
  • Tyra Biosciences, Inc. · 8-K (8.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Tyra Biosciences, Inc. (TYRA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit